因此,约有一半重度症状性二尖瓣反流患者由于手术风险较高而无法进行手术。经导管二尖瓣置换术(transcatheter mitral valve replacement, TMVR)[即经导管二尖瓣瓣中瓣置换术(transcatheter mitral valve-in-valve replacement, TMViV)和经导管二尖瓣...
研究人群 本研究入选2015年6月至2019年7月在美国295个中心使用SAPIEN3瓣膜行经导管二尖瓣瓣中瓣植入术(Transcatheter mitral valve-in-valve replacement, MViV)的1529例患者作为研究对象,其中1326例为经房间隔入路,余203例为经心尖入路。 研究目的 评估使用SAPIE...
因此,约有一半重度症状性二尖瓣反流患者由于手术风险较高而无法进行手术。经导管二尖瓣置换术(transcatheter mitral valve replacement, TMVR)[即经导管二尖瓣瓣中瓣置换术(transcatheter mitral valve-in-valve replacement, TMViV)和经导管二尖瓣环中瓣置换术(transcatheter mitral valve-in-ring replacement, TMViR)]的发...
Advanced hybrid solutions: mitral valve replacement and bailout direct vision Sapien S3 aortic implantationRamón Rodriguez Olivares
valve leaflet coaptation, do not overinflate the deployment balloon. Appropriate antibiotic prophylaxis is recommended post-procedure in patients at risk for prosthetic valve infection and endocarditis. Additional precautions for transseptal replacement of a failed mitral valve bioprosthesis include, the ...
other abnormalities in the caval vein precluding safe transvenous femoral access for transseptal approach; and the presence of an Atrial Septal Occluder Device or calcium preventing safe transseptal access. Special care must be exercised in mitral valve replacement to avoid entrapment of the subvalvular...
This cohort study assesses contemporary outcomes of mitral valve-in-valve replacement with the SAPIEN 3 transcatheter heart valve.
The Edwards SAPIEN transcatheter heart valve (Edwards Lifesciences, Irvine, California) was initially introduced as a transcatheter alternative to surgical valve replacement in elderly, inoperable patients with severe aortic stenosis 10, 11. This new heart valve system obtained Conformité Européene certif...
Procedure was complicated by valve embolization into the ascending aorta likely due to a sub-optimal positioning of prosthesis during its deployment. Patient was treated by surgical removal of stent-valve and conventional valve replacement. Patient was discharged from hospital 7 days after surgery. At...
Until recently transcatheter aortic valve replacement (TAVR) has been used principally in elderly, high-risk populations with limited life expectancy. Failure of transcatheter heart valves (THVs) due to structural valve degeneration (SVD), requiring urgent reintervention, is an uncommon occurrence. There...